| abstract |
(57) [Summary] [Object] To provide a fused 5-membered heterocyclic compound having beneficial pharmacological properties, for example, an aggregation-inhibiting action, a pharmaceutical composition containing these compounds, and a method for preparing them. Composition: 5-[(2-carboxy-ethyl) -aminocarbonyl] -1-methyl-2- [2- (4-piperidinyl) -ethyl] -benzimidazole, 5-[(2-carboxy-ethyl)- Aminocarbonyl] -1-methyl-2-[(4-piperidinyl) -aminocarbonyl]- Benzimidazole, 5- (4-carboxy-1-oxo-butyl) -1-methyl-2- [2- (4-piperidinyl) -ethyl] -benzimidazole, 1- (4-carboxy-butyl) -3- A condensed 5-membered heterocyclic compound including methyl-8- [2- (4-piperidinyl) -ethyl] -xanthine, and analogs thereof, tautomers thereof, stereoisomers including a mixture thereof, and salts thereof. |